Merck KGaA (MKGAF.PK), Darmstadt, Germany Completes Millipore Corporation (MIL) Acquisition and Launches New EMD Millipore Division (Merck Millipore Division Outside U.S. and Canada)
7/15/2010 8:48:19 AM
BILLERICA, Mass. & DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA*, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation (formerly NYSE: MIL), a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately $7.0 billion. Merck agreed to acquire Millipore on February 28, 2010 for $107 in cash per share of Millipore common stock. The closing follows the approval of the acquisition by Millipore’s shareholders at a special meeting held on June 3, 2010 and the satisfaction of other customary conditions, including antitrust clearance in the United States and Europe. Merck will now begin the process of delisting the shares of Millipore from the New York Stock Exchange and removing the shares from registration with the U.S. Securities and Exchange Commission.